Menveo 1 vial-a-c-y-w-135-DIP 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FBSZ9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,361
Award facts
- Contract value 100% obligated
- $16,361.28 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $16,361.28 delivery order to AmerisourceBergen Drug Corp on January 5, 2026, for the supply of Menveo 1 Vial A-C-Y-W-135-DIP (0.5mL), a meningococcal conjugate vaccine. The contract utilizes firm fixed pricing with an ultimate completion date of January 6, 2026, and represents a non-set-aside competitive award. Performance will occur at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is a child contract issued against AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal military and veteran healthcare procurement. The company's SPE2DX prime contract vehicle provides comprehensive global pharmaceutical support across multiple therapeutic domains, including vaccines, specialty medications, and generic drugs, serving customers such as the Defense Health Agency and U.S. Coast Guard. This award reflects the company's capability to fulfill federal medical supply requirements through open competition and its role within the DLA's broader pharmaceutical supply chain supporting military healthcare programs worldwide.
Quick answers
Who was awarded contract SPE2DR26FBSZ9?
SPE2DR26FBSZ9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 5, 2026.
How much is contract SPE2DR26FBSZ9 worth?
The government has obligated $16,361 on SPE2DR26FBSZ9.
Is contract SPE2DR26FBSZ9 an order under another contract?
Yes. SPE2DR26FBSZ9 is a delivery order under SPE2DR25D2002, an indefinite delivery contract.
Was contract SPE2DR26FBSZ9 competed?
The extent of competition for SPE2DR26FBSZ9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award